{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Bar Chart\n",
    "\n",
    "Bar chart is the bread and butter of data visualization. You can basically meet 90% of data analytics needs with bar chart."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Explore the data\n",
    "\n",
    "Polars is my favorite dataframe library. There is an interesting open-source effort in biomedical space called OpenTargets.\n",
    "\n",
    "Downloaded the (tab-separated value) from OpenTargets: "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "![Alt text](iga_neph.png)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>diseaseId</th>\n",
       "      <th>diseaseName</th>\n",
       "      <th>drugId</th>\n",
       "      <th>drugName</th>\n",
       "      <th>type</th>\n",
       "      <th>mechanismOfAction</th>\n",
       "      <th>actionType</th>\n",
       "      <th>symbol</th>\n",
       "      <th>name</th>\n",
       "      <th>phase</th>\n",
       "      <th>status</th>\n",
       "      <th>source</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>EFO_0004194</td>\n",
       "      <td>IGA glomerulonephritis</td>\n",
       "      <td>CHEMBL429910</td>\n",
       "      <td>DAPAGLIFLOZIN</td>\n",
       "      <td>Small molecule</td>\n",
       "      <td>Sodium/glucose cotransporter 2 inhibitor</td>\n",
       "      <td>Inhibitor</td>\n",
       "      <td>SLC5A2</td>\n",
       "      <td>solute carrier family 5 member 2</td>\n",
       "      <td>4</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>https://clinicaltrials.gov/ct2/show/NCT04662723</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>EFO_0004194</td>\n",
       "      <td>IGA glomerulonephritis</td>\n",
       "      <td>CHEMBL1168</td>\n",
       "      <td>RAMIPRIL</td>\n",
       "      <td>Small molecule</td>\n",
       "      <td>Angiotensin-converting enzyme inhibitor</td>\n",
       "      <td>Inhibitor</td>\n",
       "      <td>ACE</td>\n",
       "      <td>angiotensin I converting enzyme</td>\n",
       "      <td>4</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>https://clinicaltrials.gov/ct2/show/NCT04662723</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>EFO_0004194</td>\n",
       "      <td>IGA glomerulonephritis</td>\n",
       "      <td>CHEMBL1535</td>\n",
       "      <td>HYDROXYCHLOROQUINE</td>\n",
       "      <td>Small molecule</td>\n",
       "      <td>Toll-like receptor 7 antagonist</td>\n",
       "      <td>Antagonist</td>\n",
       "      <td>TLR7</td>\n",
       "      <td>toll like receptor 7</td>\n",
       "      <td>4</td>\n",
       "      <td>Completed</td>\n",
       "      <td>https://clinicaltrials.gov/ct2/show/NCT02351752</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>EFO_0004194</td>\n",
       "      <td>IGA glomerulonephritis</td>\n",
       "      <td>CHEMBL1639</td>\n",
       "      <td>ALISKIREN</td>\n",
       "      <td>Small molecule</td>\n",
       "      <td>Renin inhibitor</td>\n",
       "      <td>Inhibitor</td>\n",
       "      <td>REN</td>\n",
       "      <td>renin</td>\n",
       "      <td>4</td>\n",
       "      <td>Completed</td>\n",
       "      <td>https://clinicaltrials.gov/ct2/show/NCT00922311</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>EFO_0004194</td>\n",
       "      <td>IGA glomerulonephritis</td>\n",
       "      <td>CHEMBL4594217</td>\n",
       "      <td>CANAGLIFLOZIN</td>\n",
       "      <td>Small molecule</td>\n",
       "      <td>Sodium/glucose cotransporter 2 inhibitor</td>\n",
       "      <td>Inhibitor</td>\n",
       "      <td>SLC5A2</td>\n",
       "      <td>solute carrier family 5 member 2</td>\n",
       "      <td>4</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>https://clinicaltrials.gov/ct2/show/NCT04662723</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>EFO_0004194</td>\n",
       "      <td>IGA glomerulonephritis</td>\n",
       "      <td>CHEMBL1535</td>\n",
       "      <td>HYDROXYCHLOROQUINE</td>\n",
       "      <td>Small molecule</td>\n",
       "      <td>Toll-like receptor 9 antagonist</td>\n",
       "      <td>Antagonist</td>\n",
       "      <td>TLR9</td>\n",
       "      <td>toll like receptor 9</td>\n",
       "      <td>4</td>\n",
       "      <td>Completed</td>\n",
       "      <td>https://clinicaltrials.gov/ct2/show/NCT02351752</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>EFO_0004194</td>\n",
       "      <td>IGA glomerulonephritis</td>\n",
       "      <td>CHEMBL578</td>\n",
       "      <td>ENALAPRIL</td>\n",
       "      <td>Small molecule</td>\n",
       "      <td>Angiotensin-converting enzyme inhibitor</td>\n",
       "      <td>Inhibitor</td>\n",
       "      <td>ACE</td>\n",
       "      <td>angiotensin I converting enzyme</td>\n",
       "      <td>4</td>\n",
       "      <td>Completed</td>\n",
       "      <td>https://clinicaltrials.gov/ct2/show/NCT00367562</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>EFO_0004194</td>\n",
       "      <td>IGA glomerulonephritis</td>\n",
       "      <td>CHEMBL1456</td>\n",
       "      <td>MYCOPHENOLATE MOFETIL</td>\n",
       "      <td>Small molecule</td>\n",
       "      <td>Inosine-5'-monophosphate dehydrogenase (IMPDH)...</td>\n",
       "      <td>Inhibitor</td>\n",
       "      <td>IMPDH1</td>\n",
       "      <td>inosine monophosphate dehydrogenase 1</td>\n",
       "      <td>4</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>https://clinicaltrials.gov/ct2/show/NCT02981212</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>EFO_0004194</td>\n",
       "      <td>IGA glomerulonephritis</td>\n",
       "      <td>CHEMBL1069</td>\n",
       "      <td>VALSARTAN</td>\n",
       "      <td>Small molecule</td>\n",
       "      <td>Type-1 angiotensin II receptor antagonist</td>\n",
       "      <td>Antagonist</td>\n",
       "      <td>AGTR1</td>\n",
       "      <td>angiotensin II receptor type 1</td>\n",
       "      <td>4</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>https://clinicaltrials.gov/ct2/show/NCT02765594</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>EFO_0004194</td>\n",
       "      <td>IGA glomerulonephritis</td>\n",
       "      <td>CHEMBL1690</td>\n",
       "      <td>HYDROXYCHLOROQUINE SULFATE</td>\n",
       "      <td>Small molecule</td>\n",
       "      <td>Toll-like receptor 7 antagonist</td>\n",
       "      <td>Antagonist</td>\n",
       "      <td>TLR7</td>\n",
       "      <td>toll like receptor 7</td>\n",
       "      <td>4</td>\n",
       "      <td>Completed</td>\n",
       "      <td>https://clinicaltrials.gov/ct2/show/NCT02351752</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     diseaseId             diseaseName         drugId  \\\n",
       "0  EFO_0004194  IGA glomerulonephritis   CHEMBL429910   \n",
       "1  EFO_0004194  IGA glomerulonephritis     CHEMBL1168   \n",
       "2  EFO_0004194  IGA glomerulonephritis     CHEMBL1535   \n",
       "3  EFO_0004194  IGA glomerulonephritis     CHEMBL1639   \n",
       "4  EFO_0004194  IGA glomerulonephritis  CHEMBL4594217   \n",
       "5  EFO_0004194  IGA glomerulonephritis     CHEMBL1535   \n",
       "6  EFO_0004194  IGA glomerulonephritis      CHEMBL578   \n",
       "7  EFO_0004194  IGA glomerulonephritis     CHEMBL1456   \n",
       "8  EFO_0004194  IGA glomerulonephritis     CHEMBL1069   \n",
       "9  EFO_0004194  IGA glomerulonephritis     CHEMBL1690   \n",
       "\n",
       "                     drugName            type  \\\n",
       "0               DAPAGLIFLOZIN  Small molecule   \n",
       "1                    RAMIPRIL  Small molecule   \n",
       "2          HYDROXYCHLOROQUINE  Small molecule   \n",
       "3                   ALISKIREN  Small molecule   \n",
       "4               CANAGLIFLOZIN  Small molecule   \n",
       "5          HYDROXYCHLOROQUINE  Small molecule   \n",
       "6                   ENALAPRIL  Small molecule   \n",
       "7       MYCOPHENOLATE MOFETIL  Small molecule   \n",
       "8                   VALSARTAN  Small molecule   \n",
       "9  HYDROXYCHLOROQUINE SULFATE  Small molecule   \n",
       "\n",
       "                                   mechanismOfAction  actionType  symbol  \\\n",
       "0           Sodium/glucose cotransporter 2 inhibitor   Inhibitor  SLC5A2   \n",
       "1            Angiotensin-converting enzyme inhibitor   Inhibitor     ACE   \n",
       "2                    Toll-like receptor 7 antagonist  Antagonist    TLR7   \n",
       "3                                    Renin inhibitor   Inhibitor     REN   \n",
       "4           Sodium/glucose cotransporter 2 inhibitor   Inhibitor  SLC5A2   \n",
       "5                    Toll-like receptor 9 antagonist  Antagonist    TLR9   \n",
       "6            Angiotensin-converting enzyme inhibitor   Inhibitor     ACE   \n",
       "7  Inosine-5'-monophosphate dehydrogenase (IMPDH)...   Inhibitor  IMPDH1   \n",
       "8          Type-1 angiotensin II receptor antagonist  Antagonist   AGTR1   \n",
       "9                    Toll-like receptor 7 antagonist  Antagonist    TLR7   \n",
       "\n",
       "                                    name  phase              status  \\\n",
       "0       solute carrier family 5 member 2      4  Not yet recruiting   \n",
       "1        angiotensin I converting enzyme      4  Not yet recruiting   \n",
       "2                   toll like receptor 7      4           Completed   \n",
       "3                                  renin      4           Completed   \n",
       "4       solute carrier family 5 member 2      4  Not yet recruiting   \n",
       "5                   toll like receptor 9      4           Completed   \n",
       "6        angiotensin I converting enzyme      4           Completed   \n",
       "7  inosine monophosphate dehydrogenase 1      4      Unknown status   \n",
       "8         angiotensin II receptor type 1      4      Unknown status   \n",
       "9                   toll like receptor 7      4           Completed   \n",
       "\n",
       "                                            source  \n",
       "0  https://clinicaltrials.gov/ct2/show/NCT04662723  \n",
       "1  https://clinicaltrials.gov/ct2/show/NCT04662723  \n",
       "2  https://clinicaltrials.gov/ct2/show/NCT02351752  \n",
       "3  https://clinicaltrials.gov/ct2/show/NCT00922311  \n",
       "4  https://clinicaltrials.gov/ct2/show/NCT04662723  \n",
       "5  https://clinicaltrials.gov/ct2/show/NCT02351752  \n",
       "6  https://clinicaltrials.gov/ct2/show/NCT00367562  \n",
       "7  https://clinicaltrials.gov/ct2/show/NCT02981212  \n",
       "8  https://clinicaltrials.gov/ct2/show/NCT02765594  \n",
       "9  https://clinicaltrials.gov/ct2/show/NCT02351752  "
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import polars as pl\n",
    "\n",
    "df = pl.read_csv(\"data/EFO_0004194-known-drugs.tsv\", separator=\"\\t\")\n",
    "df.head(10).to_pandas()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Bar-chart as exploratory data analysis"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div><style>\n",
       ".dataframe > thead > tr > th,\n",
       ".dataframe > tbody > tr > td {\n",
       "  text-align: right;\n",
       "}\n",
       "</style>\n",
       "<small>shape: (86, 12)</small><table border=\"1\" class=\"dataframe\"><thead><tr><th>diseaseId</th><th>diseaseName</th><th>drugId</th><th>drugName</th><th>type</th><th>mechanismOfAction</th><th>actionType</th><th>symbol</th><th>name</th><th>phase</th><th>status</th><th>source</th></tr><tr><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>i64</td><td>str</td><td>str</td></tr></thead><tbody><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL429910&quot;</td><td>&quot;DAPAGLIFLOZIN&quot;</td><td>&quot;Small molecule…</td><td>&quot;Sodium/glucose…</td><td>&quot;Inhibitor&quot;</td><td>&quot;SLC5A2&quot;</td><td>&quot;solute carrier…</td><td>4</td><td>&quot;Not yet recrui…</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL1168&quot;</td><td>&quot;RAMIPRIL&quot;</td><td>&quot;Small molecule…</td><td>&quot;Angiotensin-co…</td><td>&quot;Inhibitor&quot;</td><td>&quot;ACE&quot;</td><td>&quot;angiotensin I …</td><td>4</td><td>&quot;Not yet recrui…</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL1535&quot;</td><td>&quot;HYDROXYCHLOROQ…</td><td>&quot;Small molecule…</td><td>&quot;Toll-like rece…</td><td>&quot;Antagonist&quot;</td><td>&quot;TLR7&quot;</td><td>&quot;toll like rece…</td><td>4</td><td>&quot;Completed&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL1639&quot;</td><td>&quot;ALISKIREN&quot;</td><td>&quot;Small molecule…</td><td>&quot;Renin inhibito…</td><td>&quot;Inhibitor&quot;</td><td>&quot;REN&quot;</td><td>&quot;renin&quot;</td><td>4</td><td>&quot;Completed&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL4594217&quot;</td><td>&quot;CANAGLIFLOZIN&quot;</td><td>&quot;Small molecule…</td><td>&quot;Sodium/glucose…</td><td>&quot;Inhibitor&quot;</td><td>&quot;SLC5A2&quot;</td><td>&quot;solute carrier…</td><td>4</td><td>&quot;Not yet recrui…</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL1535&quot;</td><td>&quot;HYDROXYCHLOROQ…</td><td>&quot;Small molecule…</td><td>&quot;Toll-like rece…</td><td>&quot;Antagonist&quot;</td><td>&quot;TLR9&quot;</td><td>&quot;toll like rece…</td><td>4</td><td>&quot;Completed&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL578&quot;</td><td>&quot;ENALAPRIL&quot;</td><td>&quot;Small molecule…</td><td>&quot;Angiotensin-co…</td><td>&quot;Inhibitor&quot;</td><td>&quot;ACE&quot;</td><td>&quot;angiotensin I …</td><td>4</td><td>&quot;Completed&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL1456&quot;</td><td>&quot;MYCOPHENOLATE …</td><td>&quot;Small molecule…</td><td>&quot;Inosine-5&#x27;-mon…</td><td>&quot;Inhibitor&quot;</td><td>&quot;IMPDH1&quot;</td><td>&quot;inosine monoph…</td><td>4</td><td>&quot;Unknown status…</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL1069&quot;</td><td>&quot;VALSARTAN&quot;</td><td>&quot;Small molecule…</td><td>&quot;Type-1 angiote…</td><td>&quot;Antagonist&quot;</td><td>&quot;AGTR1&quot;</td><td>&quot;angiotensin II…</td><td>4</td><td>&quot;Unknown status…</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL1690&quot;</td><td>&quot;HYDROXYCHLOROQ…</td><td>&quot;Small molecule…</td><td>&quot;Toll-like rece…</td><td>&quot;Antagonist&quot;</td><td>&quot;TLR7&quot;</td><td>&quot;toll like rece…</td><td>4</td><td>&quot;Completed&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL1535&quot;</td><td>&quot;HYDROXYCHLOROQ…</td><td>&quot;Small molecule…</td><td>&quot;Toll-like rece…</td><td>&quot;Antagonist&quot;</td><td>&quot;TLR9&quot;</td><td>&quot;toll like rece…</td><td>4</td><td>&quot;Unknown status…</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL608&quot;</td><td>&quot;PROBUCOL&quot;</td><td>&quot;Small molecule…</td><td>&quot;ATP-binding ca…</td><td>&quot;Inhibitor&quot;</td><td>&quot;ABCA1&quot;</td><td>&quot;ATP binding ca…</td><td>4</td><td>&quot;Completed&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL4594460&quot;</td><td>&quot;AT-1501&quot;</td><td>&quot;Unknown&quot;</td><td>&quot;CD40 ligand in…</td><td>&quot;Inhibitor&quot;</td><td>&quot;CD40LG&quot;</td><td>&quot;CD40 ligand&quot;</td><td>2</td><td>&quot;Recruiting&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL1742986&quot;</td><td>&quot;ATACICEPT&quot;</td><td>&quot;Protein&quot;</td><td>&quot;Tumor necrosis…</td><td>&quot;Inhibitor&quot;</td><td>&quot;TNFSF13&quot;</td><td>&quot;TNF superfamil…</td><td>2</td><td>&quot;Active, not re…</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL4594614&quot;</td><td>&quot;SIBEPRENLIMAB&quot;</td><td>&quot;Antibody&quot;</td><td>&quot;Tumor necrosis…</td><td>&quot;Inhibitor&quot;</td><td>&quot;TNFSF13&quot;</td><td>&quot;TNF superfamil…</td><td>2</td><td>&quot;Active, not re…</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL4594579&quot;</td><td>&quot;FELZARTAMAB&quot;</td><td>&quot;Antibody&quot;</td><td>&quot;Lymphocyte dif…</td><td>&quot;Inhibitor&quot;</td><td>&quot;CD38&quot;</td><td>&quot;CD38 molecule&quot;</td><td>2</td><td>&quot;Recruiting&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL1487&quot;</td><td>&quot;ATORVASTATIN&quot;</td><td>&quot;Small molecule…</td><td>&quot;HMG-CoA reduct…</td><td>&quot;Inhibitor&quot;</td><td>&quot;HMGCR&quot;</td><td>&quot;3-hydroxy-3-me…</td><td>2</td><td>&quot;Completed&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL3989871&quot;</td><td>&quot;AVACOPAN&quot;</td><td>&quot;Small molecule…</td><td>&quot;C5a anaphylato…</td><td>&quot;Antagonist&quot;</td><td>&quot;C5AR1&quot;</td><td>&quot;complement C5a…</td><td>2</td><td>&quot;Completed&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL1370&quot;</td><td>&quot;BUDESONIDE&quot;</td><td>&quot;Small molecule…</td><td>&quot;Glucocorticoid…</td><td>&quot;Agonist&quot;</td><td>&quot;NR3C1&quot;</td><td>&quot;nuclear recept…</td><td>2</td><td>&quot;Completed&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL2103830&quot;</td><td>&quot;FOSTAMATINIB&quot;</td><td>&quot;Small molecule…</td><td>&quot;Tyrosine-prote…</td><td>&quot;Inhibitor&quot;</td><td>&quot;SYK&quot;</td><td>&quot;spleen associa…</td><td>2</td><td>&quot;Completed&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL578&quot;</td><td>&quot;ENALAPRIL&quot;</td><td>&quot;Small molecule…</td><td>&quot;Angiotensin-co…</td><td>&quot;Inhibitor&quot;</td><td>&quot;ACE&quot;</td><td>&quot;angiotensin I …</td><td>2</td><td>&quot;Completed&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL3989516&quot;</td><td>&quot;FOSTAMATINIB D…</td><td>&quot;Small molecule…</td><td>&quot;Tyrosine-prote…</td><td>&quot;Inhibitor&quot;</td><td>&quot;SYK&quot;</td><td>&quot;spleen associa…</td><td>2</td><td>&quot;Withdrawn&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL4297722&quot;</td><td>&quot;CEMDISIRAN&quot;</td><td>&quot;Oligonucleotid…</td><td>&quot;Complement C5 …</td><td>&quot;Rnai inhibitor…</td><td>&quot;C5&quot;</td><td>&quot;complement C5&quot;</td><td>2</td><td>&quot;Active, not re…</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL4594614&quot;</td><td>&quot;SIBEPRENLIMAB&quot;</td><td>&quot;Antibody&quot;</td><td>&quot;Tumor necrosis…</td><td>&quot;Inhibitor&quot;</td><td>&quot;TNFSF13&quot;</td><td>&quot;TNF superfamil…</td><td>1</td><td>&quot;Completed&quot;</td><td>&quot;https://clinic…</td></tr></tbody></table></div>"
      ],
      "text/plain": [
       "shape: (86, 12)\n",
       "┌────────────┬────────────┬────────────┬───────────┬───┬───────────┬───────┬───────────┬───────────┐\n",
       "│ diseaseId  ┆ diseaseNam ┆ drugId     ┆ drugName  ┆ … ┆ name      ┆ phase ┆ status    ┆ source    │\n",
       "│ ---        ┆ e          ┆ ---        ┆ ---       ┆   ┆ ---       ┆ ---   ┆ ---       ┆ ---       │\n",
       "│ str        ┆ ---        ┆ str        ┆ str       ┆   ┆ str       ┆ i64   ┆ str       ┆ str       │\n",
       "│            ┆ str        ┆            ┆           ┆   ┆           ┆       ┆           ┆           │\n",
       "╞════════════╪════════════╪════════════╪═══════════╪═══╪═══════════╪═══════╪═══════════╪═══════════╡\n",
       "│ EFO_000419 ┆ IGA glomer ┆ CHEMBL4299 ┆ DAPAGLIFL ┆ … ┆ solute    ┆ 4     ┆ Not yet   ┆ https://c │\n",
       "│ 4          ┆ ulonephrit ┆ 10         ┆ OZIN      ┆   ┆ carrier   ┆       ┆ recruitin ┆ linicaltr │\n",
       "│            ┆ is         ┆            ┆           ┆   ┆ family 5  ┆       ┆ g         ┆ ials.gov/ │\n",
       "│            ┆            ┆            ┆           ┆   ┆ member 2  ┆       ┆           ┆ ct2/s…    │\n",
       "│ EFO_000419 ┆ IGA glomer ┆ CHEMBL1168 ┆ RAMIPRIL  ┆ … ┆ angiotens ┆ 4     ┆ Not yet   ┆ https://c │\n",
       "│ 4          ┆ ulonephrit ┆            ┆           ┆   ┆ in I conv ┆       ┆ recruitin ┆ linicaltr │\n",
       "│            ┆ is         ┆            ┆           ┆   ┆ erting    ┆       ┆ g         ┆ ials.gov/ │\n",
       "│            ┆            ┆            ┆           ┆   ┆ enzyme    ┆       ┆           ┆ ct2/s…    │\n",
       "│ EFO_000419 ┆ IGA glomer ┆ CHEMBL1535 ┆ HYDROXYCH ┆ … ┆ toll like ┆ 4     ┆ Completed ┆ https://c │\n",
       "│ 4          ┆ ulonephrit ┆            ┆ LOROQUINE ┆   ┆ receptor  ┆       ┆           ┆ linicaltr │\n",
       "│            ┆ is         ┆            ┆           ┆   ┆ 7         ┆       ┆           ┆ ials.gov/ │\n",
       "│            ┆            ┆            ┆           ┆   ┆           ┆       ┆           ┆ ct2/s…    │\n",
       "│ EFO_000419 ┆ IGA glomer ┆ CHEMBL1639 ┆ ALISKIREN ┆ … ┆ renin     ┆ 4     ┆ Completed ┆ https://c │\n",
       "│ 4          ┆ ulonephrit ┆            ┆           ┆   ┆           ┆       ┆           ┆ linicaltr │\n",
       "│            ┆ is         ┆            ┆           ┆   ┆           ┆       ┆           ┆ ials.gov/ │\n",
       "│            ┆            ┆            ┆           ┆   ┆           ┆       ┆           ┆ ct2/s…    │\n",
       "│ …          ┆ …          ┆ …          ┆ …         ┆ … ┆ …         ┆ …     ┆ …         ┆ …         │\n",
       "│ EFO_000419 ┆ IGA glomer ┆ CHEMBL578  ┆ ENALAPRIL ┆ … ┆ angiotens ┆ 2     ┆ Completed ┆ https://c │\n",
       "│ 4          ┆ ulonephrit ┆            ┆           ┆   ┆ in I conv ┆       ┆           ┆ linicaltr │\n",
       "│            ┆ is         ┆            ┆           ┆   ┆ erting    ┆       ┆           ┆ ials.gov/ │\n",
       "│            ┆            ┆            ┆           ┆   ┆ enzyme    ┆       ┆           ┆ ct2/s…    │\n",
       "│ EFO_000419 ┆ IGA glomer ┆ CHEMBL3989 ┆ FOSTAMATI ┆ … ┆ spleen    ┆ 2     ┆ Withdrawn ┆ https://c │\n",
       "│ 4          ┆ ulonephrit ┆ 516        ┆ NIB       ┆   ┆ associate ┆       ┆           ┆ linicaltr │\n",
       "│            ┆ is         ┆            ┆ DISODIUM  ┆   ┆ d         ┆       ┆           ┆ ials.gov/ │\n",
       "│            ┆            ┆            ┆           ┆   ┆ tyrosine  ┆       ┆           ┆ ct2/s…    │\n",
       "│            ┆            ┆            ┆           ┆   ┆ kinas…    ┆       ┆           ┆           │\n",
       "│ EFO_000419 ┆ IGA glomer ┆ CHEMBL4297 ┆ CEMDISIRA ┆ … ┆ complemen ┆ 2     ┆ Active,   ┆ https://c │\n",
       "│ 4          ┆ ulonephrit ┆ 722        ┆ N         ┆   ┆ t C5      ┆       ┆ not recru ┆ linicaltr │\n",
       "│            ┆ is         ┆            ┆           ┆   ┆           ┆       ┆ iting     ┆ ials.gov/ │\n",
       "│            ┆            ┆            ┆           ┆   ┆           ┆       ┆           ┆ ct2/s…    │\n",
       "│ EFO_000419 ┆ IGA glomer ┆ CHEMBL4594 ┆ SIBEPRENL ┆ … ┆ TNF super ┆ 1     ┆ Completed ┆ https://c │\n",
       "│ 4          ┆ ulonephrit ┆ 614        ┆ IMAB      ┆   ┆ family    ┆       ┆           ┆ linicaltr │\n",
       "│            ┆ is         ┆            ┆           ┆   ┆ member 13 ┆       ┆           ┆ ials.gov/ │\n",
       "│            ┆            ┆            ┆           ┆   ┆           ┆       ┆           ┆ ct2/s…    │\n",
       "└────────────┴────────────┴────────────┴───────────┴───┴───────────┴───────┴───────────┴───────────┘"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Data Summary\n",
    "\n",
    "The data contains:\n",
    "- row-by-row information for disease IgA glomerulonephritis (IgA nephropathy)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Exploration Steps:\n",
    "\n",
    "### Start small\n",
    "\n",
    "For starters, an easy way to explore complex datasets like this is to explore seemingly obvious ones.\n",
    "\n",
    "`status` column is relatively understandable, even if you don't come from biomedical background - 10 row preview shows "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<style>\n",
       "  #altair-viz-b6c22ba5def34702933da808b13e8cd2.vega-embed {\n",
       "    width: 100%;\n",
       "    display: flex;\n",
       "  }\n",
       "\n",
       "  #altair-viz-b6c22ba5def34702933da808b13e8cd2.vega-embed details,\n",
       "  #altair-viz-b6c22ba5def34702933da808b13e8cd2.vega-embed details summary {\n",
       "    position: relative;\n",
       "  }\n",
       "</style>\n",
       "<div id=\"altair-viz-b6c22ba5def34702933da808b13e8cd2\"></div>\n",
       "<script type=\"text/javascript\">\n",
       "  var VEGA_DEBUG = (typeof VEGA_DEBUG == \"undefined\") ? {} : VEGA_DEBUG;\n",
       "  (function(spec, embedOpt){\n",
       "    let outputDiv = document.currentScript.previousElementSibling;\n",
       "    if (outputDiv.id !== \"altair-viz-b6c22ba5def34702933da808b13e8cd2\") {\n",
       "      outputDiv = document.getElementById(\"altair-viz-b6c22ba5def34702933da808b13e8cd2\");\n",
       "    }\n",
       "    const paths = {\n",
       "      \"vega\": \"https://cdn.jsdelivr.net/npm/vega@5?noext\",\n",
       "      \"vega-lib\": \"https://cdn.jsdelivr.net/npm/vega-lib?noext\",\n",
       "      \"vega-lite\": \"https://cdn.jsdelivr.net/npm/vega-lite@5.8.0?noext\",\n",
       "      \"vega-embed\": \"https://cdn.jsdelivr.net/npm/vega-embed@6?noext\",\n",
       "    };\n",
       "\n",
       "    function maybeLoadScript(lib, version) {\n",
       "      var key = `${lib.replace(\"-\", \"\")}_version`;\n",
       "      return (VEGA_DEBUG[key] == version) ?\n",
       "        Promise.resolve(paths[lib]) :\n",
       "        new Promise(function(resolve, reject) {\n",
       "          var s = document.createElement('script');\n",
       "          document.getElementsByTagName(\"head\")[0].appendChild(s);\n",
       "          s.async = true;\n",
       "          s.onload = () => {\n",
       "            VEGA_DEBUG[key] = version;\n",
       "            return resolve(paths[lib]);\n",
       "          };\n",
       "          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);\n",
       "          s.src = paths[lib];\n",
       "        });\n",
       "    }\n",
       "\n",
       "    function showError(err) {\n",
       "      outputDiv.innerHTML = `<div class=\"error\" style=\"color:red;\">${err}</div>`;\n",
       "      throw err;\n",
       "    }\n",
       "\n",
       "    function displayChart(vegaEmbed) {\n",
       "      vegaEmbed(outputDiv, spec, embedOpt)\n",
       "        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));\n",
       "    }\n",
       "\n",
       "    if(typeof define === \"function\" && define.amd) {\n",
       "      requirejs.config({paths});\n",
       "      require([\"vega-embed\"], displayChart, err => showError(`Error loading script: ${err.message}`));\n",
       "    } else {\n",
       "      maybeLoadScript(\"vega\", \"5\")\n",
       "        .then(() => maybeLoadScript(\"vega-lite\", \"5.8.0\"))\n",
       "        .then(() => maybeLoadScript(\"vega-embed\", \"6\"))\n",
       "        .catch(showError)\n",
       "        .then(() => displayChart(vegaEmbed));\n",
       "    }\n",
       "  })({\"config\": {\"view\": {\"continuousWidth\": 300, \"continuousHeight\": 300}}, \"data\": {\"name\": \"data-d8b010d8a623bfd2a3ba7a368b00fc84\"}, \"mark\": {\"type\": \"bar\"}, \"encoding\": {\"x\": {\"aggregate\": \"distinct\", \"field\": \"drugId\", \"type\": \"quantitative\"}, \"y\": {\"field\": \"status\", \"type\": \"ordinal\"}}, \"$schema\": \"https://vega.github.io/schema/vega-lite/v5.8.0.json\", \"datasets\": {\"data-d8b010d8a623bfd2a3ba7a368b00fc84\": [{\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL429910\", \"drugName\": \"DAPAGLIFLOZIN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Sodium/glucose cotransporter 2 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"SLC5A2\", \"name\": \"solute carrier family 5 member 2\", \"phase\": 4, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04662723\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1168\", \"drugName\": \"RAMIPRIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Angiotensin-converting enzyme inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"ACE\", \"name\": \"angiotensin I converting enzyme\", \"phase\": 4, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04662723\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1535\", \"drugName\": \"HYDROXYCHLOROQUINE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 7 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR7\", \"name\": \"toll like receptor 7\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02351752\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1639\", \"drugName\": \"ALISKIREN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Renin inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"REN\", \"name\": \"renin\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00922311\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594217\", \"drugName\": \"CANAGLIFLOZIN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Sodium/glucose cotransporter 2 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"SLC5A2\", \"name\": \"solute carrier family 5 member 2\", \"phase\": 4, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04662723\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1535\", \"drugName\": \"HYDROXYCHLOROQUINE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 9 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR9\", \"name\": \"toll like receptor 9\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02351752\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL578\", \"drugName\": \"ENALAPRIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Angiotensin-converting enzyme inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"ACE\", \"name\": \"angiotensin I converting enzyme\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00367562\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH1\", \"name\": \"inosine monophosphate dehydrogenase 1\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02981212\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1069\", \"drugName\": \"VALSARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02765594\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1690\", \"drugName\": \"HYDROXYCHLOROQUINE SULFATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 7 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR7\", \"name\": \"toll like receptor 7\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02351752\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1535\", \"drugName\": \"HYDROXYCHLOROQUINE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 9 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR9\", \"name\": \"toll like receptor 9\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02765594\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL608\", \"drugName\": \"PROBUCOL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"ATP-binding cassette sub-family A member 1 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"ABCA1\", \"name\": \"ATP binding cassette subfamily A member 1\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00426348\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL191\", \"drugName\": \"LOSARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02231125\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL635\", \"drugName\": \"PREDNISONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT01758120\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1690\", \"drugName\": \"HYDROXYCHLOROQUINE SULFATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 9 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR9\", \"name\": \"toll like receptor 9\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02765594\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1690\", \"drugName\": \"HYDROXYCHLOROQUINE SULFATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 9 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR9\", \"name\": \"toll like receptor 9\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02351752\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1201576\", \"drugName\": \"RITUXIMAB\", \"type\": \"Antibody\", \"mechanismOfAction\": \"B-lymphocyte antigen CD20 binding agent\", \"actionType\": \"Binding agent\", \"symbol\": \"MS4A1\", \"name\": \"membrane spanning 4-domains A1\", \"phase\": 4, \"status\": \"Recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04525729\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1069\", \"drugName\": \"VALSARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00367562,https://clinicaltrials.gov/ct2/show/NCT00426348\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH2\", \"name\": \"inosine monophosphate dehydrogenase 2\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00863252\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL635\", \"drugName\": \"PREDNISONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 4, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03218852\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH2\", \"name\": \"inosine monophosphate dehydrogenase 2\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02981212\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1201576\", \"drugName\": \"RITUXIMAB\", \"type\": \"Antibody\", \"mechanismOfAction\": \"B-lymphocyte antigen CD20 binding agent\", \"actionType\": \"Binding agent\", \"symbol\": \"MS4A1\", \"name\": \"membrane spanning 4-domains A1\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02571842\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1690\", \"drugName\": \"HYDROXYCHLOROQUINE SULFATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 7 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR7\", \"name\": \"toll like receptor 7\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02765594\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1201081\", \"drugName\": \"METHYLPREDNISOLONE SODIUM SUCCINATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00755859\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1237\", \"drugName\": \"LISINOPRIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Angiotensin-converting enzyme inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"ACE\", \"name\": \"angiotensin I converting enzyme\", \"phase\": 4, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04662723\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1201265\", \"drugName\": \"METHYLPREDNISOLONE HEMISUCCINATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00755859\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1535\", \"drugName\": \"HYDROXYCHLOROQUINE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 7 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR7\", \"name\": \"toll like receptor 7\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02765594\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1201576\", \"drugName\": \"RITUXIMAB\", \"type\": \"Antibody\", \"mechanismOfAction\": \"B-lymphocyte antigen CD20 binding agent\", \"actionType\": \"Binding agent\", \"symbol\": \"MS4A1\", \"name\": \"membrane spanning 4-domains A1\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00498368\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH1\", \"name\": \"inosine monophosphate dehydrogenase 1\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00863252\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL2048484\", \"drugName\": \"CANAGLIFLOZIN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Sodium/glucose cotransporter 2 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"SLC5A2\", \"name\": \"solute carrier family 5 member 2\", \"phase\": 4, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04662723\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL191\", \"drugName\": \"LOSARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT01115426\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL2107830\", \"drugName\": \"EMPAGLIFLOZIN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Sodium/glucose cotransporter 2 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"SLC5A2\", \"name\": \"solute carrier family 5 member 2\", \"phase\": 4, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04662723\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL191\", \"drugName\": \"LOSARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 4, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04662723\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1168\", \"drugName\": \"RAMIPRIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Angiotensin-converting enzyme inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"ACE\", \"name\": \"angiotensin I converting enzyme\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT01115426\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL846\", \"drugName\": \"CALCITRIOL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Vitamin D receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"VDR\", \"name\": \"vitamin D receptor\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00319761\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1542\", \"drugName\": \"AZATHIOPRINE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Amidophosphoribosyltransferase inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"PPAT\", \"name\": \"phosphoribosyl pyrophosphate amidotransferase\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00755859\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1639\", \"drugName\": \"ALISKIREN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Renin inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"REN\", \"name\": \"renin\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00870493\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH2\", \"name\": \"inosine monophosphate dehydrogenase 2\", \"phase\": 3, \"status\": \"Terminated\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00318474\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL191\", \"drugName\": \"LOSARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 3, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03357653\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL9194\", \"drugName\": \"ATRASENTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Endothelin receptor ET-A antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"EDNRA\", \"name\": \"endothelin receptor type A\", \"phase\": 3, \"status\": \"Recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04573478\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4298195\", \"drugName\": \"NARSOPLIMAB\", \"type\": \"Antibody\", \"mechanismOfAction\": \"Mannan-binding lectin serine protease 2 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"MASP2\", \"name\": \"MBL associated serine protease 2\", \"phase\": 3, \"status\": \"Recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03608033\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH1\", \"name\": \"inosine monophosphate dehydrogenase 1\", \"phase\": 3, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02187900\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594448\", \"drugName\": \"IPTACOPAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Complement factor B inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"CFB\", \"name\": \"complement factor B\", \"phase\": 3, \"status\": \"Recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04578834,https://clinicaltrials.gov/ct2/show/NCT04557462\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL131\", \"drugName\": \"PREDNISOLONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00554502\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1201081\", \"drugName\": \"METHYLPREDNISOLONE SODIUM SUCCINATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00657059\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL635\", \"drugName\": \"PREDNISONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT01392833\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH2\", \"name\": \"inosine monophosphate dehydrogenase 2\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00657059\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL131\", \"drugName\": \"PREDNISOLONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 3, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT05510323\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL2107877\", \"drugName\": \"BLISIBIMOD\", \"type\": \"Protein\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13B inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13B\", \"name\": \"TNF superfamily member 13b\", \"phase\": 3, \"status\": \"Withdrawn\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02052219\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1513\", \"drugName\": \"IRBESARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00657059\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH1\", \"name\": \"inosine monophosphate dehydrogenase 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00657059\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL650\", \"drugName\": \"METHYLPREDNISOLONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT01392833,https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT00554502\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1513\", \"drugName\": \"IRBESARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 3, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03762850\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1201265\", \"drugName\": \"METHYLPREDNISOLONE HEMISUCCINATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00657059\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL539423\", \"drugName\": \"SPARSENTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Endothelin receptor ET-A antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"EDNRA\", \"name\": \"endothelin receptor type A\", \"phase\": 3, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03762850\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1542\", \"drugName\": \"AZATHIOPRINE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Amidophosphoribosyltransferase inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"PPAT\", \"name\": \"phosphoribosyl pyrophosphate amidotransferase\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00554502,https://clinicaltrials.gov/ct2/show/NCT01392833\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL191\", \"drugName\": \"LOSARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02232776\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL539423\", \"drugName\": \"SPARSENTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 3, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03762850\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH1\", \"name\": \"inosine monophosphate dehydrogenase 1\", \"phase\": 3, \"status\": \"Terminated\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00318474\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1200622\", \"drugName\": \"PARICALCITOL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Vitamin D receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"VDR\", \"name\": \"vitamin D receptor\", \"phase\": 3, \"status\": \"Withdrawn\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00599963\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH2\", \"name\": \"inosine monophosphate dehydrogenase 2\", \"phase\": 3, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02187900\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL650\", \"drugName\": \"METHYLPREDNISOLONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 3, \"status\": \"Recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04833374\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL2107877\", \"drugName\": \"BLISIBIMOD\", \"type\": \"Protein\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13B inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13B\", \"name\": \"TNF superfamily member 13b\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02062684\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1742986\", \"drugName\": \"ATACICEPT\", \"type\": \"Protein\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13B inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13B\", \"name\": \"TNF superfamily member 13b\", \"phase\": 2, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04716231\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1742986\", \"drugName\": \"ATACICEPT\", \"type\": \"Protein\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13B inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13B\", \"name\": \"TNF superfamily member 13b\", \"phase\": 2, \"status\": \"Terminated\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02808429\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594448\", \"drugName\": \"IPTACOPAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Complement factor B inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"CFB\", \"name\": \"complement factor B\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03373461\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL635\", \"drugName\": \"PREDNISONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00004448\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1742986\", \"drugName\": \"ATACICEPT\", \"type\": \"Protein\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13\", \"name\": \"TNF superfamily member 13\", \"phase\": 2, \"status\": \"Terminated\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02808429\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL393220\", \"drugName\": \"ATORVASTATIN CALCIUM\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"HMG-CoA reductase inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"HMGCR\", \"name\": \"3-hydroxy-3-methylglutaryl-CoA reductase\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00396721\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL131\", \"drugName\": \"PREDNISOLONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 2, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02662283\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594462\", \"drugName\": \"BATIRAXCEPT\", \"type\": \"Protein\", \"mechanismOfAction\": \"Growth arrest-specific protein 6 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"GAS6\", \"name\": \"growth arrest specific 6\", \"phase\": 2, \"status\": \"Terminated\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04042623\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL413\", \"drugName\": \"SIROLIMUS\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"FK506-binding protein 1A inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"FKBP1A\", \"name\": \"FKBP prolyl isomerase 1A\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00396721\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL2103830\", \"drugName\": \"FOSTAMATINIB\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Tyrosine-protein kinase SYK inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"SYK\", \"name\": \"spleen associated tyrosine kinase\", \"phase\": 2, \"status\": \"Withdrawn\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02433236\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL269732\", \"drugName\": \"TACROLIMUS\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"FK506-binding protein 1A inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"FKBP1A\", \"name\": \"FKBP prolyl isomerase 1A\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT01224028\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594460\", \"drugName\": \"AT-1501\", \"type\": \"Unknown\", \"mechanismOfAction\": \"CD40 ligand inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"CD40LG\", \"name\": \"CD40 ligand\", \"phase\": 2, \"status\": \"Recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT05125068\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1742986\", \"drugName\": \"ATACICEPT\", \"type\": \"Protein\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13\", \"name\": \"TNF superfamily member 13\", \"phase\": 2, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04716231\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594614\", \"drugName\": \"SIBEPRENLIMAB\", \"type\": \"Antibody\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13\", \"name\": \"TNF superfamily member 13\", \"phase\": 2, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04287985\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594579\", \"drugName\": \"FELZARTAMAB\", \"type\": \"Antibody\", \"mechanismOfAction\": \"Lymphocyte differentiation antigen CD38 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"CD38\", \"name\": \"CD38 molecule\", \"phase\": 2, \"status\": \"Recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT05065970\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1487\", \"drugName\": \"ATORVASTATIN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"HMG-CoA reductase inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"HMGCR\", \"name\": \"3-hydroxy-3-methylglutaryl-CoA reductase\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00396721\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL3989871\", \"drugName\": \"AVACOPAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"C5a anaphylatoxin chemotactic receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"C5AR1\", \"name\": \"complement C5a receptor 1\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02384317\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1370\", \"drugName\": \"BUDESONIDE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00767221\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL2103830\", \"drugName\": \"FOSTAMATINIB\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Tyrosine-protein kinase SYK inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"SYK\", \"name\": \"spleen associated tyrosine kinase\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02112838\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL578\", \"drugName\": \"ENALAPRIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Angiotensin-converting enzyme inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"ACE\", \"name\": \"angiotensin I converting enzyme\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00396721\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL3989516\", \"drugName\": \"FOSTAMATINIB DISODIUM\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Tyrosine-protein kinase SYK inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"SYK\", \"name\": \"spleen associated tyrosine kinase\", \"phase\": 2, \"status\": \"Withdrawn\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02433236\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4297722\", \"drugName\": \"CEMDISIRAN\", \"type\": \"Oligonucleotide\", \"mechanismOfAction\": \"Complement C5 mRNA RNAi inhibitor\", \"actionType\": \"Rnai inhibitor\", \"symbol\": \"C5\", \"name\": \"complement C5\", \"phase\": 2, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03841448\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594614\", \"drugName\": \"SIBEPRENLIMAB\", \"type\": \"Antibody\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13\", \"name\": \"TNF superfamily member 13\", \"phase\": 1, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03719443\"}]}}, {\"mode\": \"vega-lite\"});\n",
       "</script>"
      ],
      "text/plain": [
       "alt.Chart(...)"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import altair as alt\n",
    "\n",
    "alt.Chart(df).mark_bar().encode(\n",
    "    x=\"distinct(drugId):Q\",\n",
    "    y=\"status:O\",\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "```{note}\n",
    "\n",
    "Titles like \"Distinct of drugID\" won't get you any points for good data visualization. \n",
    "\n",
    "```"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<style>\n",
       "  #altair-viz-f66f457ab50041fab360827f7730c7c3.vega-embed {\n",
       "    width: 100%;\n",
       "    display: flex;\n",
       "  }\n",
       "\n",
       "  #altair-viz-f66f457ab50041fab360827f7730c7c3.vega-embed details,\n",
       "  #altair-viz-f66f457ab50041fab360827f7730c7c3.vega-embed details summary {\n",
       "    position: relative;\n",
       "  }\n",
       "</style>\n",
       "<div id=\"altair-viz-f66f457ab50041fab360827f7730c7c3\"></div>\n",
       "<script type=\"text/javascript\">\n",
       "  var VEGA_DEBUG = (typeof VEGA_DEBUG == \"undefined\") ? {} : VEGA_DEBUG;\n",
       "  (function(spec, embedOpt){\n",
       "    let outputDiv = document.currentScript.previousElementSibling;\n",
       "    if (outputDiv.id !== \"altair-viz-f66f457ab50041fab360827f7730c7c3\") {\n",
       "      outputDiv = document.getElementById(\"altair-viz-f66f457ab50041fab360827f7730c7c3\");\n",
       "    }\n",
       "    const paths = {\n",
       "      \"vega\": \"https://cdn.jsdelivr.net/npm/vega@5?noext\",\n",
       "      \"vega-lib\": \"https://cdn.jsdelivr.net/npm/vega-lib?noext\",\n",
       "      \"vega-lite\": \"https://cdn.jsdelivr.net/npm/vega-lite@5.8.0?noext\",\n",
       "      \"vega-embed\": \"https://cdn.jsdelivr.net/npm/vega-embed@6?noext\",\n",
       "    };\n",
       "\n",
       "    function maybeLoadScript(lib, version) {\n",
       "      var key = `${lib.replace(\"-\", \"\")}_version`;\n",
       "      return (VEGA_DEBUG[key] == version) ?\n",
       "        Promise.resolve(paths[lib]) :\n",
       "        new Promise(function(resolve, reject) {\n",
       "          var s = document.createElement('script');\n",
       "          document.getElementsByTagName(\"head\")[0].appendChild(s);\n",
       "          s.async = true;\n",
       "          s.onload = () => {\n",
       "            VEGA_DEBUG[key] = version;\n",
       "            return resolve(paths[lib]);\n",
       "          };\n",
       "          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);\n",
       "          s.src = paths[lib];\n",
       "        });\n",
       "    }\n",
       "\n",
       "    function showError(err) {\n",
       "      outputDiv.innerHTML = `<div class=\"error\" style=\"color:red;\">${err}</div>`;\n",
       "      throw err;\n",
       "    }\n",
       "\n",
       "    function displayChart(vegaEmbed) {\n",
       "      vegaEmbed(outputDiv, spec, embedOpt)\n",
       "        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));\n",
       "    }\n",
       "\n",
       "    if(typeof define === \"function\" && define.amd) {\n",
       "      requirejs.config({paths});\n",
       "      require([\"vega-embed\"], displayChart, err => showError(`Error loading script: ${err.message}`));\n",
       "    } else {\n",
       "      maybeLoadScript(\"vega\", \"5\")\n",
       "        .then(() => maybeLoadScript(\"vega-lite\", \"5.8.0\"))\n",
       "        .then(() => maybeLoadScript(\"vega-embed\", \"6\"))\n",
       "        .catch(showError)\n",
       "        .then(() => displayChart(vegaEmbed));\n",
       "    }\n",
       "  })({\"config\": {\"view\": {\"continuousWidth\": 300, \"continuousHeight\": 300}}, \"data\": {\"name\": \"data-d8b010d8a623bfd2a3ba7a368b00fc84\"}, \"mark\": {\"type\": \"bar\"}, \"encoding\": {\"x\": {\"aggregate\": \"distinct\", \"field\": \"drugId\", \"title\": \"Number of Unique Drugs\", \"type\": \"quantitative\"}, \"y\": {\"field\": \"mechanismOfAction\", \"title\": null, \"type\": \"ordinal\"}}, \"$schema\": \"https://vega.github.io/schema/vega-lite/v5.8.0.json\", \"datasets\": {\"data-d8b010d8a623bfd2a3ba7a368b00fc84\": [{\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL429910\", \"drugName\": \"DAPAGLIFLOZIN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Sodium/glucose cotransporter 2 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"SLC5A2\", \"name\": \"solute carrier family 5 member 2\", \"phase\": 4, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04662723\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1168\", \"drugName\": \"RAMIPRIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Angiotensin-converting enzyme inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"ACE\", \"name\": \"angiotensin I converting enzyme\", \"phase\": 4, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04662723\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1535\", \"drugName\": \"HYDROXYCHLOROQUINE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 7 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR7\", \"name\": \"toll like receptor 7\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02351752\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1639\", \"drugName\": \"ALISKIREN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Renin inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"REN\", \"name\": \"renin\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00922311\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594217\", \"drugName\": \"CANAGLIFLOZIN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Sodium/glucose cotransporter 2 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"SLC5A2\", \"name\": \"solute carrier family 5 member 2\", \"phase\": 4, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04662723\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1535\", \"drugName\": \"HYDROXYCHLOROQUINE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 9 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR9\", \"name\": \"toll like receptor 9\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02351752\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL578\", \"drugName\": \"ENALAPRIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Angiotensin-converting enzyme inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"ACE\", \"name\": \"angiotensin I converting enzyme\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00367562\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH1\", \"name\": \"inosine monophosphate dehydrogenase 1\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02981212\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1069\", \"drugName\": \"VALSARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02765594\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1690\", \"drugName\": \"HYDROXYCHLOROQUINE SULFATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 7 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR7\", \"name\": \"toll like receptor 7\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02351752\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1535\", \"drugName\": \"HYDROXYCHLOROQUINE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 9 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR9\", \"name\": \"toll like receptor 9\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02765594\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL608\", \"drugName\": \"PROBUCOL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"ATP-binding cassette sub-family A member 1 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"ABCA1\", \"name\": \"ATP binding cassette subfamily A member 1\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00426348\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL191\", \"drugName\": \"LOSARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02231125\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL635\", \"drugName\": \"PREDNISONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT01758120\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1690\", \"drugName\": \"HYDROXYCHLOROQUINE SULFATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 9 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR9\", \"name\": \"toll like receptor 9\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02765594\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1690\", \"drugName\": \"HYDROXYCHLOROQUINE SULFATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 9 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR9\", \"name\": \"toll like receptor 9\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02351752\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1201576\", \"drugName\": \"RITUXIMAB\", \"type\": \"Antibody\", \"mechanismOfAction\": \"B-lymphocyte antigen CD20 binding agent\", \"actionType\": \"Binding agent\", \"symbol\": \"MS4A1\", \"name\": \"membrane spanning 4-domains A1\", \"phase\": 4, \"status\": \"Recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04525729\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1069\", \"drugName\": \"VALSARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00367562,https://clinicaltrials.gov/ct2/show/NCT00426348\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH2\", \"name\": \"inosine monophosphate dehydrogenase 2\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00863252\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL635\", \"drugName\": \"PREDNISONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 4, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03218852\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH2\", \"name\": \"inosine monophosphate dehydrogenase 2\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02981212\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1201576\", \"drugName\": \"RITUXIMAB\", \"type\": \"Antibody\", \"mechanismOfAction\": \"B-lymphocyte antigen CD20 binding agent\", \"actionType\": \"Binding agent\", \"symbol\": \"MS4A1\", \"name\": \"membrane spanning 4-domains A1\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02571842\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1690\", \"drugName\": \"HYDROXYCHLOROQUINE SULFATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 7 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR7\", \"name\": \"toll like receptor 7\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02765594\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1201081\", \"drugName\": \"METHYLPREDNISOLONE SODIUM SUCCINATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00755859\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1237\", \"drugName\": \"LISINOPRIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Angiotensin-converting enzyme inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"ACE\", \"name\": \"angiotensin I converting enzyme\", \"phase\": 4, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04662723\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1201265\", \"drugName\": \"METHYLPREDNISOLONE HEMISUCCINATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00755859\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1535\", \"drugName\": \"HYDROXYCHLOROQUINE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Toll-like receptor 7 antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"TLR7\", \"name\": \"toll like receptor 7\", \"phase\": 4, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02765594\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1201576\", \"drugName\": \"RITUXIMAB\", \"type\": \"Antibody\", \"mechanismOfAction\": \"B-lymphocyte antigen CD20 binding agent\", \"actionType\": \"Binding agent\", \"symbol\": \"MS4A1\", \"name\": \"membrane spanning 4-domains A1\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00498368\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH1\", \"name\": \"inosine monophosphate dehydrogenase 1\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00863252\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL2048484\", \"drugName\": \"CANAGLIFLOZIN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Sodium/glucose cotransporter 2 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"SLC5A2\", \"name\": \"solute carrier family 5 member 2\", \"phase\": 4, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04662723\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL191\", \"drugName\": \"LOSARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT01115426\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL2107830\", \"drugName\": \"EMPAGLIFLOZIN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Sodium/glucose cotransporter 2 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"SLC5A2\", \"name\": \"solute carrier family 5 member 2\", \"phase\": 4, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04662723\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL191\", \"drugName\": \"LOSARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 4, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04662723\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1168\", \"drugName\": \"RAMIPRIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Angiotensin-converting enzyme inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"ACE\", \"name\": \"angiotensin I converting enzyme\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT01115426\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL846\", \"drugName\": \"CALCITRIOL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Vitamin D receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"VDR\", \"name\": \"vitamin D receptor\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00319761\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1542\", \"drugName\": \"AZATHIOPRINE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Amidophosphoribosyltransferase inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"PPAT\", \"name\": \"phosphoribosyl pyrophosphate amidotransferase\", \"phase\": 4, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00755859\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1639\", \"drugName\": \"ALISKIREN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Renin inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"REN\", \"name\": \"renin\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00870493\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH2\", \"name\": \"inosine monophosphate dehydrogenase 2\", \"phase\": 3, \"status\": \"Terminated\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00318474\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL191\", \"drugName\": \"LOSARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 3, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03357653\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL9194\", \"drugName\": \"ATRASENTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Endothelin receptor ET-A antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"EDNRA\", \"name\": \"endothelin receptor type A\", \"phase\": 3, \"status\": \"Recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04573478\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4298195\", \"drugName\": \"NARSOPLIMAB\", \"type\": \"Antibody\", \"mechanismOfAction\": \"Mannan-binding lectin serine protease 2 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"MASP2\", \"name\": \"MBL associated serine protease 2\", \"phase\": 3, \"status\": \"Recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03608033\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH1\", \"name\": \"inosine monophosphate dehydrogenase 1\", \"phase\": 3, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02187900\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594448\", \"drugName\": \"IPTACOPAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Complement factor B inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"CFB\", \"name\": \"complement factor B\", \"phase\": 3, \"status\": \"Recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04578834,https://clinicaltrials.gov/ct2/show/NCT04557462\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL131\", \"drugName\": \"PREDNISOLONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00554502\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1201081\", \"drugName\": \"METHYLPREDNISOLONE SODIUM SUCCINATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00657059\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL635\", \"drugName\": \"PREDNISONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT01392833\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH2\", \"name\": \"inosine monophosphate dehydrogenase 2\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00657059\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL131\", \"drugName\": \"PREDNISOLONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 3, \"status\": \"Not yet recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT05510323\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL2107877\", \"drugName\": \"BLISIBIMOD\", \"type\": \"Protein\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13B inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13B\", \"name\": \"TNF superfamily member 13b\", \"phase\": 3, \"status\": \"Withdrawn\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02052219\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1513\", \"drugName\": \"IRBESARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00657059\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH1\", \"name\": \"inosine monophosphate dehydrogenase 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00657059\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL650\", \"drugName\": \"METHYLPREDNISOLONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT01392833,https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT00554502\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1513\", \"drugName\": \"IRBESARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 3, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03762850\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1201265\", \"drugName\": \"METHYLPREDNISOLONE HEMISUCCINATE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00657059\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL539423\", \"drugName\": \"SPARSENTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Endothelin receptor ET-A antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"EDNRA\", \"name\": \"endothelin receptor type A\", \"phase\": 3, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03762850\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1542\", \"drugName\": \"AZATHIOPRINE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Amidophosphoribosyltransferase inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"PPAT\", \"name\": \"phosphoribosyl pyrophosphate amidotransferase\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00554502,https://clinicaltrials.gov/ct2/show/NCT01392833\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL191\", \"drugName\": \"LOSARTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 3, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02232776\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL539423\", \"drugName\": \"SPARSENTAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Type-1 angiotensin II receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"AGTR1\", \"name\": \"angiotensin II receptor type 1\", \"phase\": 3, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03762850\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH1\", \"name\": \"inosine monophosphate dehydrogenase 1\", \"phase\": 3, \"status\": \"Terminated\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00318474\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1200622\", \"drugName\": \"PARICALCITOL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Vitamin D receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"VDR\", \"name\": \"vitamin D receptor\", \"phase\": 3, \"status\": \"Withdrawn\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00599963\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1456\", \"drugName\": \"MYCOPHENOLATE MOFETIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"IMPDH2\", \"name\": \"inosine monophosphate dehydrogenase 2\", \"phase\": 3, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02187900\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL650\", \"drugName\": \"METHYLPREDNISOLONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 3, \"status\": \"Recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04833374\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL2107877\", \"drugName\": \"BLISIBIMOD\", \"type\": \"Protein\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13B inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13B\", \"name\": \"TNF superfamily member 13b\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02062684\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1742986\", \"drugName\": \"ATACICEPT\", \"type\": \"Protein\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13B inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13B\", \"name\": \"TNF superfamily member 13b\", \"phase\": 2, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04716231\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1742986\", \"drugName\": \"ATACICEPT\", \"type\": \"Protein\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13B inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13B\", \"name\": \"TNF superfamily member 13b\", \"phase\": 2, \"status\": \"Terminated\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02808429\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594448\", \"drugName\": \"IPTACOPAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Complement factor B inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"CFB\", \"name\": \"complement factor B\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03373461\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL635\", \"drugName\": \"PREDNISONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00004448\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1742986\", \"drugName\": \"ATACICEPT\", \"type\": \"Protein\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13\", \"name\": \"TNF superfamily member 13\", \"phase\": 2, \"status\": \"Terminated\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02808429\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL393220\", \"drugName\": \"ATORVASTATIN CALCIUM\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"HMG-CoA reductase inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"HMGCR\", \"name\": \"3-hydroxy-3-methylglutaryl-CoA reductase\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00396721\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL131\", \"drugName\": \"PREDNISOLONE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 2, \"status\": \"Unknown status\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02662283\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594462\", \"drugName\": \"BATIRAXCEPT\", \"type\": \"Protein\", \"mechanismOfAction\": \"Growth arrest-specific protein 6 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"GAS6\", \"name\": \"growth arrest specific 6\", \"phase\": 2, \"status\": \"Terminated\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04042623\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL413\", \"drugName\": \"SIROLIMUS\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"FK506-binding protein 1A inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"FKBP1A\", \"name\": \"FKBP prolyl isomerase 1A\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00396721\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL2103830\", \"drugName\": \"FOSTAMATINIB\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Tyrosine-protein kinase SYK inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"SYK\", \"name\": \"spleen associated tyrosine kinase\", \"phase\": 2, \"status\": \"Withdrawn\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02433236\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL269732\", \"drugName\": \"TACROLIMUS\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"FK506-binding protein 1A inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"FKBP1A\", \"name\": \"FKBP prolyl isomerase 1A\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT01224028\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594460\", \"drugName\": \"AT-1501\", \"type\": \"Unknown\", \"mechanismOfAction\": \"CD40 ligand inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"CD40LG\", \"name\": \"CD40 ligand\", \"phase\": 2, \"status\": \"Recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT05125068\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1742986\", \"drugName\": \"ATACICEPT\", \"type\": \"Protein\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13\", \"name\": \"TNF superfamily member 13\", \"phase\": 2, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04716231\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594614\", \"drugName\": \"SIBEPRENLIMAB\", \"type\": \"Antibody\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13\", \"name\": \"TNF superfamily member 13\", \"phase\": 2, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT04287985\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594579\", \"drugName\": \"FELZARTAMAB\", \"type\": \"Antibody\", \"mechanismOfAction\": \"Lymphocyte differentiation antigen CD38 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"CD38\", \"name\": \"CD38 molecule\", \"phase\": 2, \"status\": \"Recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT05065970\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1487\", \"drugName\": \"ATORVASTATIN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"HMG-CoA reductase inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"HMGCR\", \"name\": \"3-hydroxy-3-methylglutaryl-CoA reductase\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00396721\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL3989871\", \"drugName\": \"AVACOPAN\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"C5a anaphylatoxin chemotactic receptor antagonist\", \"actionType\": \"Antagonist\", \"symbol\": \"C5AR1\", \"name\": \"complement C5a receptor 1\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02384317\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL1370\", \"drugName\": \"BUDESONIDE\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Glucocorticoid receptor agonist\", \"actionType\": \"Agonist\", \"symbol\": \"NR3C1\", \"name\": \"nuclear receptor subfamily 3 group C member 1\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00767221\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL2103830\", \"drugName\": \"FOSTAMATINIB\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Tyrosine-protein kinase SYK inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"SYK\", \"name\": \"spleen associated tyrosine kinase\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02112838\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL578\", \"drugName\": \"ENALAPRIL\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Angiotensin-converting enzyme inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"ACE\", \"name\": \"angiotensin I converting enzyme\", \"phase\": 2, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT00396721\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL3989516\", \"drugName\": \"FOSTAMATINIB DISODIUM\", \"type\": \"Small molecule\", \"mechanismOfAction\": \"Tyrosine-protein kinase SYK inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"SYK\", \"name\": \"spleen associated tyrosine kinase\", \"phase\": 2, \"status\": \"Withdrawn\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT02433236\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4297722\", \"drugName\": \"CEMDISIRAN\", \"type\": \"Oligonucleotide\", \"mechanismOfAction\": \"Complement C5 mRNA RNAi inhibitor\", \"actionType\": \"Rnai inhibitor\", \"symbol\": \"C5\", \"name\": \"complement C5\", \"phase\": 2, \"status\": \"Active, not recruiting\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03841448\"}, {\"diseaseId\": \"EFO_0004194\", \"diseaseName\": \"IGA glomerulonephritis\", \"drugId\": \"CHEMBL4594614\", \"drugName\": \"SIBEPRENLIMAB\", \"type\": \"Antibody\", \"mechanismOfAction\": \"Tumor necrosis factor ligand superfamily member 13 inhibitor\", \"actionType\": \"Inhibitor\", \"symbol\": \"TNFSF13\", \"name\": \"TNF superfamily member 13\", \"phase\": 1, \"status\": \"Completed\", \"source\": \"https://clinicaltrials.gov/ct2/show/NCT03719443\"}]}}, {\"mode\": \"vega-lite\"});\n",
       "</script>"
      ],
      "text/plain": [
       "alt.Chart(...)"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import altair as alt\n",
    "\n",
    "alt.Chart(df).mark_bar().encode(\n",
    "    x=alt.X(\"distinct(drugId):Q\").title(\"Number of Unique Drugs\"), \n",
    "    y=alt.Y(\"mechanismOfAction:O\").title(None),\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "data-expressions-XOHyUNvQ-py3.10",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}